Group enterprises in recognition of the annual advanced
Release time:
2020-07-22
News from our newspaper 1# April 23 - 2# August 1 , Shanghai Beika Pharmaceutical Technology Co., Ltd., Yunnan Jianfeng Cement Company, Daye Jianfeng Cement Company, Pharmaceutical Company, Tianjin Jianfeng Natural Products Company and Cable Company successively held summary commendation meetings to summarize the work of the past year, to commend the outstanding collectives and individuals of each enterprise in 2018 , and put forward the working ideas for the new year.
Shanghai North Carolina Pharmaceutical Annual Ceremony invited partners who care about and support the growth of Shanghai North Carolina in the past year. Kang Litao, General Manager of Shanghai North Carolina, reviewed the achievements made by Shanghai North Carolina in 2018 , and set a higher goal for 2019 , encouraging everyone to be pragmatic and innovative and strive for the industry leader. At the meeting, the leaders of the pharmaceutical company and Shanghai North Carolina presented awards to the advanced personnel of the year in turn. This year, the advanced collective award was added, which was won by Shanghai North Carolina Research and Development Department. The representatives of the award-winning employees also made a brief speech, expressing their willingness to grow and progress with Shanghai North Carolina while thanking the company for its affirmation. At the Yunnan peak summary commendation meeting held on
, Zhou Jiping, general manager of Yunnan peak, objectively analyzed the situation and tasks faced by Yunnan peak in 2019 , determined the assessment indicators of Yunnan peak environment and occupational health and safety, product sales volume, sales revenue and payment recovery in 2019 , and deployed the work in 2019 . The meeting also commended the advanced collectives and individuals in the year 2018 .
1 26 , daye peak cement company held a summary commendation meeting. Zhang Fengliang, deputy general manager of the group company and general manager of daye peak, introduced the important work in 2018 , analyzed the opportunities brought by the national economic development to the cement market in 2019 and the impact of national policies on the cement market, put forward measures for improvement in the next stage, and made detailed arrangements for the work in 2019 . On the evening of
26 and 30 , Daye Peak also held a Spring Festival group meeting in batches. All the staff gathered together to have a group dinner to welcome the Spring Festival. On the morning of
1 April 30 , Jianfeng Pharmaceutical Company held a 2018 annual summary commendation meeting to summarize the work of the past year, commend the outstanding collectives and individuals of Pharmaceutical Company 2018 , and put forward the working ideas for the new year. On behalf of the management team of the pharmaceutical company, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company, reviewed the main work situation in 2018 from the aspects of marketing management, scientific and technological innovation, internal control, quality management, foreign cooperation, party and government work group work, analyzed the industry policy and development trend in 2019 , and made arrangements for the key work in 2019 . On behalf of the pharmaceutical company, Huang Jinlong signed a new year's economic target responsibility system with the heads of its subordinate enterprises. Jiang Xiaomeng, chairman of
Group Company and chairman of Pharmaceutical Company, also made a written speech, hoping that in the new year, Pharmaceutical Company can speed up the development of new drugs, drug consistency evaluation, Jinxi internationalization project and North Carolina Zhongwang technological transformation project. Firmly establish the concept of all services for marketing, ensure quality, supply and service; To comprehensively improve the market control ability of peak pharmaceutical industry, enhance the deep integration ability of enterprises and enhance the coordination and handling ability of enterprises and government relations. With full spirit and high morale, we will ensure the successful completion of all tasks in 2019 .
1 May 30 , Tianjin Jianfeng Natural Products Company held 2019 Spring Festival Gala and 2018 Advanced Commendation Conference. While reviewing and summarizing the work of 2018 and looking forward to 2019 , the advanced collectives and individuals of 2018 were commended, and programs were organized to celebrate the Spring Festival. In 2018 , the sales revenue of Natural Products Company reached a record high. Liu Dan, general manager of Natural Products Company, expressed his gratitude to all employees for their contributions. At the same time, he encouraged all employees not to relax in the new year, continue to create achievements with full enthusiasm, and present a gift to welcome the establishment of Natural Products Company 20st anniversary.
2 May , the cable company commended the advanced collectives and individuals of 2018 after the morning meeting. The meeting also held a farewell ceremony for the retirement of General Manager Li Jinzhi. Employees came to the stage to express Li's training, care and gratitude over the years. Zhang Ci, the new general manager of the cable company, put forward the development ideas and hopes for the new year. (Li Yimin, Liu Fengbin, Shi Wen Ting, Yang Huiping Ni Yingzhen Chen Zichan, Lu Chaofang)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page